Emanuel, E. J., Buchanan, A., Chan, S. Y., Fabre, C., Halliday, D., Heath, J., … Persad, G. (2021). What are the obligations of pharmaceutical companies in a global health emergency? Lancet (London, England), 398(10304), 1015–1020. https://doi.org/10.1016/s0140-6736(21)01378-7

Emanuel, Ezekiel J., Allen Buchanan, Shuk Ying Chan, Cécile Fabre, Daniel Halliday, Joseph Heath, Lisa Herzog, et al. “What are the obligations of pharmaceutical companies in a global health emergency?” Lancet (London, England) 398, no. 10304 (September 2021): 1015–20. https://doi.org/10.1016/s0140-6736(21)01378-7.

Emanuel EJ, Buchanan A, Chan SY, Fabre C, Halliday D, Heath J, et al. What are the obligations of pharmaceutical companies in a global health emergency? Lancet (London, England). 2021 Sep;398(10304):1015–20.

Emanuel, Ezekiel J., et al. “What are the obligations of pharmaceutical companies in a global health emergency?” Lancet (London, England), vol. 398, no. 10304, Sept. 2021, pp. 1015–20. Epmc, doi:10.1016/s0140-6736(21)01378-7.

Emanuel EJ, Buchanan A, Chan SY, Fabre C, Halliday D, Heath J, Herzog L, Leland RJ, McCoy MS, Norheim OF, Saenz C, Schaefer GO, Tan K-C, Wellman CH, Wolff J, Persad G. What are the obligations of pharmaceutical companies in a global health emergency? Lancet (London, England). 2021 Sep;398(10304):1015–1020.